Nomifensine: A Review of its Pharmacological Properties and Therapeutic Efficacy in Depressive Illness

@article{Brogden2012NomifensineAR,
  title={Nomifensine: A Review of its Pharmacological Properties and Therapeutic Efficacy in Depressive Illness},
  author={Rex N. Brogden and Rennie C. Heel and Trevor M. Speight and Graeme S. Avery},
  journal={Drugs},
  year={2012},
  volume={18},
  pages={1-24}
}
SummarySynopsis: Nomifensine1 is a tetrahydroisoquinoline antidepressant which is chemically unrelated to the tricyclic or tetracyclic antidepressants, the monoamine oxidase inhibitors or the recently introduced agents. Nomifensine resembles the tricyclic antidepressants in many of its pharmacological effects in animal models of depressive illness, but differs from them in that it strongly inhibits the re-uptake of dopamine as well as noradrenaline and is a relatively weak inhibitor of… 
Zimelidine: A Review of its Pharmacological Properties and Therapeutic Efficacy in Depressive Illness
TLDR
Clinical experience with zimelidine to date has been limited, and further well designed studies are required to define the role of the drug more clearly in treating depressive illness compared with other antidepressants, and particularly to define whether some types of depression may respond more readily to zIMelidine than to other antidepressants.
Increased sexual function with nomifensine
TLDR
Sexual dysfunction occurs early in depression and recovery is relatively slow compared to that from other depressive symptoms, so nomifensine is a powerful inhibitor of dopamine re-uptake at central synapses and acts as an indirect dopamine agonist.
Current Antidepressant Drugs: Their Clinical Use
TLDR
Besides being useful for treating depression, antidepressants may be used for treating enuresis, chronically painful states, obsessive-compulsive-phobic states, acute panic attacks and cataplectic attacks in narcoleptics.
Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancers
TLDR
The results demonstrate the preferential involvement of adrenergic systems in the control of cataplexy and, presumably, REM sleep atonia and demonstrate that canine narcolepsy is a useful tool in assessing the pharmacological specificity of antidepressant drugs.
Tolerance of daily single compared to space dose of merital.
TLDR
Merital (Nomifensine) is a tetrahydroiso quinolene which is structurally unrelated to the tricyclics or to the mono amino-oxidase inhibiters which has been suggested that its mechanism of action is due to potent inhibition of dopamine reuptake at the synaptic terminals.
Clobazam in combination with nomifensine (HOE 8476): Effects on mood, sleep, and psychomotor performance relating to car‐driving ability
The effects of three dose regimens of HOE 8476, a combination of nomifensine (25 mg) and clobazam (7.5 mg), placebo, and a combination of amitriptyline (25 mg) and chlordiazepoxide (10 mg) were
Stability of developed colour of “BM” glucose monitoring strips
TLDR
Sexual dysfunction occurs early in depression and recovery is relatively slow compared to that from other depressive symptoms, so nomifensine is a powerful inhibitor of dopamine re-uptake at central synapses and acts as an indirect dopamine agonist.
Nomifensine and amitriptyline in the treatment of depression
ABSTRACT– Nomifensine, an antidepressive agent acting like a dopamine agonist, was investigated in a randomized double‐blind comparison with amitriptyline in 29 patients fulfilling the RDC criteria
A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety
TLDR
It is suggested that a variety of tricyclic and novel anti-depressant drugs acquire anxiolytic properties following chronic administration.
Dopamine-like activities of an aminopyridazine derivative, CM 30366: A behavioural study
TLDR
The results indicate that CM 30366 is a potent atypical dopamine-like drug of potential therapeutic usefulness.
...
...

References

SHOWING 1-10 OF 20 REFERENCES
Phar macokinetics of nomiFell 5 ine in impaired renal Iunc - tion
  • British Jou rnal of Oinical Phar macoloty tSllppl . 2 )
Inlerac - lio n between I ' IOmifensine and alcohol in normal sllbj ( cts : a sim ulWlCOUs kinetic and dynamic stud y Dynamic inl < : raction of I ' IOmifelllline with alcohol
    The effect of bIoctina ~ boWnine uplate on ampheWnin - induced circlina behllviour m mice . . iIh ulli \ lolenl destruction of Slriatal dopamiDer ' lic nerve terminals
    • Jownal of Pharmaq - and Pl \ arTnaCoIOiY
    An inve ntory for measu ring depression
    • Archiv es of ~ neral Psychiatry
    • 1977
    Nomifell 5 ine and its derivatives as ll ' OMible 10015 for siudyin , amine uptake
    • European Journal of Pharm
    • 1977
    Poisoning by tricyclic anOdcprewml drop . Gene ral and plLarmacokineti < : considerations
    • Internalional Journal of Cli nical Pllarmacology
    Nom ifens ine in the treatment of depression : A standard - controlled clinical study
    • Psychop ha rmaco logy Bulletin
    Tricyclic antidepres : san l drop and car - dial : Ql ) nIlUCUool
    • Progress in NCIlfOohydloplwma
    Nomirens ine in the trea tment of depression : A report on the Canadian part of a ulU \ SoCultural study
    • Psychopharmacology Bulletin
    IOinische Untersuchungen mil dem Anti - depresUv lUll Nomifensin
    • WaIcba ' ( Ed ) SYSlemauzation
    ...
    ...